Maat, M.P.M. de

study level patient fibrinogen haplotype factor polymorphism association disease plasma stroke effect protein blood thrombosis group variation result ischemic stroke control allele table genotype analysis treatment ischemic rotterdam population heart thromb activity plasma fibrinogen levels platelet fibrinogen levels atherosclerosi risk factors netherland signi assay restenosi difference phase receptor c-reactive protein event frequency method signi ficantly subject artery participant reference pressure rotterdam study brinogen venou concentration coagulation adamt smoking individual women vitamin infarction diabetes response c-reactive sample inhibitor model ratio hypertension venous thrombosis erasmu value crp levels center therapy von willebrand factor expression